Anthony A. Hyman
Fondateur chez Dewpoint Therapeutics, Inc.
Profil
Anthony A.
Hyman is the founder of Cenix BioScience GmbH, which was founded in 1999.
He held the title of Gründer from 1999 to 2009.
He is also the founder of Dewpoint Therapeutics, Inc., which was founded in 2018.
Currently, Dr. Hyman is a Member-Governing Board at the Research Centre of Excellence in Mechanobiology.
In the past, he worked as a Director at the Max-Planck-Institute for Molecular Genetics.
Additionally, he held the position of Principal at The European Molecular Biology Laboratory from 1993 to 1998.
Dr. Hyman obtained his doctorate degree from the University of Cambridge in 1988.
Postes actifs de Anthony A. Hyman
| Sociétés | Poste | Début |
|---|---|---|
Dewpoint Therapeutics, Inc.
 Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | Fondateur | 01/08/2018 |
Research Centre of Excellence in Mechanobiology
 Research Centre of Excellence in Mechanobiology Miscellaneous Commercial ServicesCommercial Services The Research Centre of Excellence in Mechanobiology conducts research and development in the field of life and biological sciences. The private company is based in Singapore, Singapore. The Singaporean company was founded in [year] by Paul Matsudaira and Michael Sheetz. | Directeur/Membre du Conseil | - |
Anciens postes connus de Anthony A. Hyman
| Sociétés | Poste | Fin |
|---|---|---|
| The European Molecular Biology Laboratory | Corporate Officer/Principal | 02/01/1998 |
| Max-Planck-Institute for Molecular Genetics | Directeur/Membre du Conseil | - |
Cenix BioScience GmbH
 Cenix BioScience GmbH Miscellaneous Commercial ServicesCommercial Services Cenix BioScience is a contract research organization specialized in combining advanced applications of RNAi with high content phenotypic analyses to enhance and accelerate the discovery and pre-clinical development of novel therapeutics. Cenix has built up a solid track record, successfully advancing therapeutic programs for numerous major industry and academic partners by addressing the specific needs of each through fully-customized, cutting-edge research offerings covering a wide range of disease fields. The well-established core capabilities in high throughput RNAi and multi-parametric microscopy assays have yielded optimized protocols in a broad and ever-growing collection of cultured cell models, and are now complemented by microRNA-focused experimentation and in vivo applications of synthetic siRNAs. As such, Cenix is a mature and fully-proven industrial research provider, applying the highest of scientific best practices and offering a breadth and depth of expertise second to none world wide | Fondateur | - |
Formation de Anthony A. Hyman
| University of Cambridge | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Cenix BioScience GmbH
Cenix BioScience GmbH Miscellaneous Commercial ServicesCommercial Services Cenix BioScience is a contract research organization specialized in combining advanced applications of RNAi with high content phenotypic analyses to enhance and accelerate the discovery and pre-clinical development of novel therapeutics. Cenix has built up a solid track record, successfully advancing therapeutic programs for numerous major industry and academic partners by addressing the specific needs of each through fully-customized, cutting-edge research offerings covering a wide range of disease fields. The well-established core capabilities in high throughput RNAi and multi-parametric microscopy assays have yielded optimized protocols in a broad and ever-growing collection of cultured cell models, and are now complemented by microRNA-focused experimentation and in vivo applications of synthetic siRNAs. As such, Cenix is a mature and fully-proven industrial research provider, applying the highest of scientific best practices and offering a breadth and depth of expertise second to none world wide | Commercial Services |
Research Centre of Excellence in Mechanobiology
Research Centre of Excellence in Mechanobiology Miscellaneous Commercial ServicesCommercial Services The Research Centre of Excellence in Mechanobiology conducts research and development in the field of life and biological sciences. The private company is based in Singapore, Singapore. The Singaporean company was founded in [year] by Paul Matsudaira and Michael Sheetz. | Commercial Services |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | Health Technology |